<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34502460</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>17</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Transcriptomic Meta-Analysis Shows Lipid Metabolism Dysregulation as an Early Pathological Mechanism in the Spinal Cord of SOD1 Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9553</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22179553</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a multifactorial and complex fatal degenerative disorder. A number of pathological mechanisms that lead to motor neuron death have been identified, although there are many unknowns in the disease aetiology of ALS. Alterations in lipid metabolism are well documented in the progression of ALS, both at the systemic level and in the spinal cord of mouse models and ALS patients. The origin of these lipid alterations remains unclear. This study aims to identify early lipid metabolic pathways altered before systemic metabolic symptoms in the spinal cord of mouse models of ALS. To do this, we performed a transcriptomic analysis of the spinal cord of <i>SOD1<sup>G93A</sup></i> mice at an early disease stage, followed by a robust transcriptomic meta-analysis using publicly available RNA-seq data from the spinal cord of SOD1 mice at early and late symptomatic disease stages. The meta-analyses identified few lipid metabolic pathways dysregulated early that were exacerbated at symptomatic stages; mainly cholesterol biosynthesis, ceramide catabolism, and eicosanoid synthesis pathways. We present an insight into the pathological mechanisms in ALS, confirming that lipid metabolic alterations are transcriptionally dysregulated and are central to ALS aetiology, opening new options for the treatment of these devastating conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Beltr&#xe1;n</LastName><ForeName>Luis C</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0001-6086-8301</Identifier><AffiliationInfo><Affiliation>Neurological Disorders Group, Hospital Cl&#xed;nico San Carlos, IdISSC, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godoy-Corchuelo</LastName><ForeName>Juan Miguel</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-8552-9218</Identifier><AffiliationInfo><Affiliation>Neurological Disorders Group, Hospital Cl&#xed;nico San Carlos, IdISSC, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losa-Fontangordo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurological Disorders Group, Hospital Cl&#xed;nico San Carlos, IdISSC, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Debbie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mammalian Genetics Unit, MRC Harwell Institute, Oxfordshire OX11 0RD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matias-Guiu</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurological Disorders Group, Hospital Cl&#xed;nico San Carlos, IdISSC, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrochano</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0958-0083</Identifier><AffiliationInfo><Affiliation>Neurological Disorders Group, Hospital Cl&#xed;nico San Carlos, IdISSC, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018-T1/BMD-10731</GrantID><Agency>Consejer&#xed;a de Educaci&#xf3;n, Juventud y Deporte, Comunidad de Madrid</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.14.-</RegistryNumber><NameOfSubstance UI="D013250">Steroid Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.38</RegistryNumber><NameOfSubstance UI="C507384">cholesterol 25-hydroxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="Y">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013250" MajorTopicYN="N">Steroid Hydroxylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RNA-seq</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">cholesterol</Keyword><Keyword MajorTopicYN="N">lipid metabolism</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34502460</ArticleId><ArticleId IdType="pmc">PMC8431303</ArticleId><ArticleId IdType="doi">10.3390/ijms22179553</ArticleId><ArticleId IdType="pii">ijms22179553</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P.C., Hentati A., Donaldson D.H., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Zhou Z.-R., Che C.-H., Liu C.-Y., He R.-L., Huang H.-P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., Fagegaltier D., Phatnani H., Harms M.B. Genetics of amyotrophic lateral sclerosis. Curr. Genet. Med. Rep. 2020;8:121&#x2013;131. doi: 10.1007/s40142-020-00194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-020-00194-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton J., Hillard C.J., Spector A.A., Watkins P.A. Brain uptake and utilization of fatty acids, lipids and lipoproteins: Application to neurological disorders. J. Mol. Neurosci. 2007;33:2&#x2013;11. doi: 10.1007/s12031-007-0060-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-007-0060-1</ArticleId><ArticleId IdType="pubmed">17901539</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mantgem M.R.J., van Eijk R.P.A., van der Burgh H.K., Tan H.H.G., Westeneng H.-J., van Es M.A., Veldink J.H., van den Berg L.H. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2020;91:867&#x2013;875. doi: 10.1136/jnnp-2020-322909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Murthy S.B., Wilson A.M., Qureshi S.U., Amro M.J., Wheaton M., Simpson E., Harati Y., Strutt A.M., York M.K., et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph. Lateral Scler. 2010;11:542&#x2013;548. doi: 10.3109/17482968.2010.482592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.482592</ArticleId><ArticleId IdType="pubmed">20500116</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C., Calvo A., Grassano M., Canosa A., Manera U., D&#x2019;Ovidio F., Bombaci A., Bersano E., Mazzini L., Mora G., et al. Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort. J. Neurol. Neurosurg. Psychiatry. 2019;90:666&#x2013;673. doi: 10.1136/jnnp-2018-319611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Corcia P., Fergani A., de Aguilar J.-L.G., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J.-J., Lacomblez L., Loeffler J.-P., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Rene F., de Aguilar J.-L.G., Loeffler J.-P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Dorst J., Dreyhaupt J., Weishaupt J.H., Kassubek J., Weiland U., Meyer T., Petri S., Hermann A., Emmer A., et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann. Neurol. 2020;87:206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills A.-M., Hubbard J., Macklin E., Glass J., Tandan R., Simpson E.P., Brooks B., Gelinas D., Mitsumoto H., Mozaffar T., et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065&#x2013;2072. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>De Aguilar J.-L.G. Lipid biomarkers for amyotrophic lateral sclerosis. Front. Neurol. 2019;10:284. doi: 10.3389/fneur.2019.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00284</ArticleId><ArticleId IdType="pmc">PMC6458258</ArticleId><ArticleId IdType="pubmed">31019485</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J., K&#xfc;hnlein P., Hendrich C., Kassubek J., Sperfeld A.D., Ludolph A.C. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho A.B., Pinto I.F.D., Dantas L.S., Xavier A.M., Inague A., Faria R.L., Medeiros M.H., Glezer I., Yoshinaga M.Y., Miyamoto S. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci. Rep. 2019;9:1&#x2013;14. doi: 10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 2002;52:448&#x2013;457. doi: 10.1002/ana.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharaoh G., Sataranatarajan K., Street K., Hill S., Gregston J., Ahn B., Kinter C., Kinter M., van Remmen H. Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Front. Neurosci. 2019;13:487. doi: 10.3389/fnins.2019.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00487</ArticleId><ArticleId IdType="pmc">PMC6554287</ArticleId><ArticleId IdType="pubmed">31213966</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra F.P., Saris C.G.J., van Rheenen W., Franke L., Jansen R.C., van Es M.A., van Vught P.W.J., Blauw H.M., Groen E.J.N., Horvath S., et al. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS ONE. 2012;7:e35333. doi: 10.1371/journal.pone.0035333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035333</ArticleId><ArticleId IdType="pmc">PMC3324559</ArticleId><ArticleId IdType="pubmed">22509407</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E. Erratum: Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation (Science (1772)) Science. 1995;269:149. doi: 10.1126/science.269.5221.149-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.269.5221.149-a</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Yu J., Sardi S.P., Shihabuddin L.S. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis. Sci. Rep. 2021;11:803. doi: 10.1038/s41598-020-80378-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80378-y</ArticleId><ArticleId IdType="pmc">PMC7804278</ArticleId><ArticleId IdType="pubmed">33436868</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau A., Marot G., Jaffr&#xe9;zic F. Differential meta-analysis of RNA-seq data from multiple studies. BMC Bioinform. 2014;15:91. doi: 10.1186/1471-2105-15-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-15-91</ArticleId><ArticleId IdType="pmc">PMC4021464</ArticleId><ArticleId IdType="pubmed">24678608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N.A., van der Schouw Y.T., Fischer K., Sizoo E.M., Huisman M.H.B., Veldink J.H., van den Berg L.H. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2011;82:638&#x2013;642. doi: 10.1136/jnnp.2010.236752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.W., Kim S.-M., Kim H.-J., Kim J.-E., Park K.S., Kim S.H., Lee K.-W., Sung J.-J. Hypolipidemia in patients with amyotrophic lateral sclerosis: A possible gender difference? J. Clin. Neurol. 2013;9:125&#x2013;129. doi: 10.3988/jcn.2013.9.2.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2013.9.2.125</ArticleId><ArticleId IdType="pmc">PMC3633190</ArticleId><ArticleId IdType="pubmed">23626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-M., Kim H., Kim J.-E., Park K.S., Sung J.-J., Kim S.H., Lee K.-W. Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice. PLoS ONE. 2011;6:e17985. doi: 10.1371/journal.pone.0017985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017985</ArticleId><ArticleId IdType="pmc">PMC3064597</ArticleId><ArticleId IdType="pubmed">21464953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P., Zhou X. Causal effects of blood lipids on amyotrophic lateral sclerosis: A Mendelian randomization study. Hum. Mol. Genet. 2019;28:688&#x2013;697. doi: 10.1093/hmg/ddy384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A., A&#x10d;imovi&#x10d; J., L&#xf6;vgren-Sandblom A., Parini P., Andersen P.M., Bj&#xf6;rkhem I. Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor. PLoS ONE. 2014;9:e113619. doi: 10.1371/journal.pone.0113619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113619</ArticleId><ArticleId IdType="pmc">PMC4240598</ArticleId><ArticleId IdType="pubmed">25415378</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J., Yutuc E., Crick P.J., Gustafsson J.-A., Warner M., Roman G., Talbot K., Gray E., Griffiths W.J., Turner M.R., et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Jensen E.H., Yu J., Sardi S.P., Bialas A.R., Taksir T.V., Bangari D.S., Shihabuddin L.S. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. J. Neurosci. 2020;40:9137&#x2013;9147. doi: 10.1523/JNEUROSCI.1388-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1388-20.2020</ArticleId><ArticleId IdType="pmc">PMC7673008</ArticleId><ArticleId IdType="pubmed">33051352</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed A.A., Genov&#xe9; G., Li T., L&#xfc;tjohann D., Olin M., Mast N., Pikuleva I., Crick P., Wang Y., Griffiths W., et al. Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain. J. Biol. Chem. 2014;289:23712&#x2013;23722. doi: 10.1074/jbc.M114.556159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.556159</ArticleId><ArticleId IdType="pmc">PMC4156098</ArticleId><ArticleId IdType="pubmed">24973215</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkhem I. Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 2006;260:493&#x2013;508. doi: 10.1111/j.1365-2796.2006.01725.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2006.01725.x</ArticleId><ArticleId IdType="pubmed">17116000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkhem I., Meaney S. Brain Cholesterol: Long Secret Life Behind a Barrier. Arter. Thromb. Vasc. Biol. 2004;24:806&#x2013;815. doi: 10.1161/01.ATV.0000120374.59826.1b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000120374.59826.1b</ArticleId><ArticleId IdType="pubmed">14764421</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X.W., Nandar W., Neely E.B., Simmons Z., Connor J.R. Statins accelerate disease progression and shorten survival in SOD1G93A mice. Muscle Nerve. 2016;54:284&#x2013;291. doi: 10.1002/mus.25048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25048</ArticleId><ArticleId IdType="pmc">PMC5848093</ArticleId><ArticleId IdType="pubmed">26799243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nefussy B., Hirsch J., Cudkowicz M.E., Drory V.E. Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis. J. Neurol. Sci. 2011;300:23&#x2013;27. doi: 10.1016/j.jns.2010.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.10.011</ArticleId><ArticleId IdType="pubmed">21056430</ArticleId></ArticleIdList></Reference><Reference><Citation>Reboldi A., Dang E., McDonald J.G., Liang G., Russell D., Cyster J.G. 25-hydroxycholesterol suppresses interleukin-1&#x2014;Driven inflammation downstream of type I interferon. Science. 2014;345:679&#x2013;684. doi: 10.1126/science.1254790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254790</ArticleId><ArticleId IdType="pmc">PMC4289637</ArticleId><ArticleId IdType="pubmed">25104388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-M., Noh M.-Y., Kim H., Cheon S.-Y., Lee K.M., Lee J., Cha E., Park K.S., Lee K.-W., Sung J.-J., et al. 25-hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8:11855&#x2013;11867. doi: 10.18632/oncotarget.14416.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14416</ArticleId><ArticleId IdType="pmc">PMC5355309</ArticleId><ArticleId IdType="pubmed">28060747</ArticleId></ArticleIdList></Reference><Reference><Citation>Marelli C., Lamari F., Rainteau D., Lafourcade A., Banneau G., Humbert L., Monin M.-L., Petit E., Debs R., Castelnovo G., et al. Plasma oxysterols: Biomarkers for diagnosis and treatment in spastic paraplegia type 5. Brain. 2018;141:72&#x2013;84. doi: 10.1093/brain/awx297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx297</ArticleId><ArticleId IdType="pubmed">29228183</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet-Pons J., Sen N.-E., Arsovi&#x107; A., Almaguer-Mederos L.-E., Halbach M.V., Key J., D&#xf6;ring C., Kerksiek A., Picchiarelli G., Cassel R., et al. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol. Dis. 2021;152:105289. doi: 10.1016/j.nbd.2021.105289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105289</ArticleId><ArticleId IdType="pubmed">33577922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickman O.J., Baple E.L., Crosby A.H. Lipid metabolic pathways converge in motor neuron degenerative diseases. Brain. 2020;143:1073&#x2013;1087. doi: 10.1093/brain/awz382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz382</ArticleId><ArticleId IdType="pmc">PMC7174042</ArticleId><ArticleId IdType="pubmed">31848577</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Treleaven C.M., Pacheco J., Cooper S., Bao C., Abraham M., Cromwell M., Sardi S.P., Chuang W.-L., Sidman R.L., et al. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2015;112:8100&#x2013;8105. doi: 10.1073/pnas.1508767112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508767112</ArticleId><ArticleId IdType="pmc">PMC4491749</ArticleId><ArticleId IdType="pubmed">26056266</ArticleId></ArticleIdList></Reference><Reference><Citation>Potenza R.L., de Simone R., Armida M., Mazziotti V., P&#xe8;zzola A., Popoli P., Minghetti L. Fingolimod: A disease-modifier drug in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics. 2016;13:918&#x2013;927. doi: 10.1007/s13311-016-0462-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0462-2</ArticleId><ArticleId IdType="pmc">PMC5081121</ArticleId><ArticleId IdType="pubmed">27456702</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomonov Y., Hadad N., Levy R. Reduction of cytosolic phospholipase A2&#x3b1; upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm. 2016;13:134. doi: 10.1186/s12974-016-0602-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0602-y</ArticleId><ArticleId IdType="pmc">PMC4888471</ArticleId><ArticleId IdType="pubmed">27250836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N., Kakita A., Takahashi H., Ihara Y., Nobukuni K., Fujimura H., Sakoda S., Kobayashi M. Increased expression and activation of cytosolic phospholipase A2 in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2010;119:345&#x2013;354. doi: 10.1007/s00401-009-0636-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0636-7</ArticleId><ArticleId IdType="pubmed">20066429</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Goldacre R., Ramagopalan S., Talbot K., Goldacre M.J. Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study. Neurology. 2013;81:1222&#x2013;1225. doi: 10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhou Y., Chen Y., Gu J. Fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884&#x2013;i890. doi: 10.1093/bioinformatics/bty560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty560</ArticleId><ArticleId IdType="pmc">PMC6129281</ArticleId><ArticleId IdType="pubmed">30423086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Paggi J.M., Park C., Bennett C., Salzberg S.L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 2019;37:907&#x2013;915. doi: 10.1038/s41587-019-0201-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0201-4</ArticleId><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Smyth G.K., Shi W. Feature counts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Wang J., Jaehnig E.J., Shi Z., Zhang B. WebGestalt 2019: Gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199&#x2013;W205. doi: 10.1093/nar/gkz401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz401</ArticleId><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri P., Sirota M., Butte A.J. Ten years of pathway analysis: Current approaches and outstanding challenges. PLoS Comput. Biol. 2012;8:e1002375. doi: 10.1371/journal.pcbi.1002375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1002375</ArticleId><ArticleId IdType="pmc">PMC3285573</ArticleId><ArticleId IdType="pubmed">22383865</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;del E., Fisher R.A. Statistical methods for research workers, 14. aufl., Oliver &amp; Boyd, Edinburgh, London 1970. XIII, 362 S., 12 abb., 74 tab., 40 s. Biom. Z. 1971;13:429&#x2013;430. doi: 10.1002/bimj.19710130623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bimj.19710130623</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P., et al. STRING v11: Protein&#x2013;protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>